Gedivumab, CAS 1807954-17-1

Product Description: Gedivumab (MHAA4549A; RG7745) is a human monoclonal antibody that targets influenza A virus (IAV) with high specificity and binds to the highly conserved stem region of the IAV haemagglutinin protein, thereby preventing haemagglutinin maturation and blocking haemagglutinin-mediated membrane fusion in the intranucleosome. Gedivumab can be used in IAV infection disease studies[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Jeremy J Lim, et al. Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5437-44. 

CAS Number: 1807954-17-1

Molecular Weight: N/A

Compound Purity: 95.11

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Influenza Virus

• Artikelnummer: MEXHY-P99637-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99637-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated